References
Hill R, Kuijper S, Lindsey J et al (2015) Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease. Cancer Cell 27:72–84
Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123:473–484
Louis D (2007) WHO classification of tumours of the central nervous system. IARC Press, Lyon
Ramaswamy V, Remke M, Bouffet E et al (2013) Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol. 14(12):1200–1207
Taylor MD, Northcott P, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465–472
Wang X, Dubuc, A, Ramaswamy V et al (2015) Medulloblastoma subgroups remain stable across primary and metastatic compartments. Acta Neuropathol. doi:10.1007/s00401-015-1389-0 (in press)
Acknowledgments
We thank Michael Schmidt for excellent assistance with histology. This work was supported by grants from the Friedrich-Baur-Stiftung, Georg und Traud Gravenhorst-Stiftung (to J.P.), Deutsche Krebshilfe (Max-Eder junior research program), the Wilhelm Sander Foundation and the Else-Kröner-Fresenius Foundation (to U.S.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pöschl, J., Koch, A. & Schüller, U. Histological subtype of medulloblastoma frequently changes upon recurrence. Acta Neuropathol 129, 459–461 (2015). https://doi.org/10.1007/s00401-015-1397-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-015-1397-0